In conclusion, our study demonstrated that miR-124 suppressed inflammatory responses and inhibited macrophage apoptosis during the development atherosclerosis by targeting p38/MAPK pathway (Figure 8). This evidence concerns the gene MAPK1 and atherosclerosis.